Overview

Effect of Green Tea (Epigallocatechin Gallate) on Albuminuria in Patients With Diabetic Nephropathy.

Status:
Completed
Trial end date:
2015-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the safety and effect of green tea (epigallocatechin gallate) in albuminuria in diabetic patients and nephropathy.
Phase:
Phase 2
Details
Lead Sponsor:
University of Campinas, Brazil
Treatments:
Angiotensin Receptor Antagonists
Epigallocatechin gallate